Skip to main content

GMP approach to overseas manufacturers of medicines and biologicals during the COVID-19 pandemic

Update – MRA GMP Clearances expiring between December 2022 and December 2023

Information about the TGA's approach to Good Manufacturing Practice (GMP) inspections and clearances for overseas manufacturers of medicines and biologicals during the COVID-19 pandemic.

Published

Related content

Help us improve the Therapeutic Goods Administration site